The influence of GLP-1 receptor agonist on the heart rate using holter electrocardiography and power spectrum analysis on heart rate variability

The influence of GLP-1 receptor agonist on the heart rate using holter electrocardiography and power spectrum analysis on heart rate variability - The influence of GLP-1 receptor agonist on the heart rate

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000017770

Enrollment

Registered

2015-06-02

Start date

2014-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 diabetes

Interventions

Liraglutide group Lixisenatide group

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: patient with type 2 DM doing a hospitalizing for diabetes Patients with no history of treatment to GLP-1 or DDP-4 inhibitor

Exclusion criteria

Exclusion criteria: Type 1 DM history of arrythmia Severe diabetic neuropathy history of pancreatitis Pregnancy

Design outcomes

Primary

Measure	Time frame
24h-heart rate Holter electrocardiograph Power spectrum analysis before or after 2h meal and night time glucose	—

Countries

Japan

Contacts

Public ContactNakatani Yuki

Dokkyomedical university nikko medical center Diabates and endcrinology

yu-naka@dokkyomed.ac.jp0288-76-1515

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026